Daniel Faga sold $639K of AnaptysBio (ANAB)

Executed Jan 8, disclosed Jan 9, 1 day later.

Value, as filed

$639K

14,281 sh × $44.71

Executed

Jan 8

the trade date, as filed

Disclosed

Jan 9

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Daniel Faga President, CEO profile →

Daniel Faga (President, CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in AnaptysBio, Inc. (ANAB). The largest single filing was $928K of ANAB (15,017 sh across 5 lots, as filed), executed Mar 27.

The name

ANAB

AnaptysBio, Inc. ANAB · Healthcare · 25 filings in 24 months ticker →

Healthcare · AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel Faga in ANAB

ANABSALE AnaptysBio, Inc. $928K
15,017 sh across 5 lots
Exec Mar 27
Filed Mar 27 · 5:30 PM ET ANABSALE AnaptysBio, Inc. $415K
9,202 sh × $45.11
Exec Jan 7
Filed Jan 8 · 5:30 PM ET ANABSALE AnaptysBio, Inc. $662K
15,309 sh × $43.26
Exec Jan 5
Filed Jan 6 · 5:30 PM ET